Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
企業コードACON
会社名Aclarion Inc
上場日Apr 22, 2022
最高経営責任者「CEO」Mr. Brent Ness
従業員数6
証券種類Ordinary Share
決算期末Apr 22
本社所在地8181 Arista Place
都市BROOMFIELD
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号80021
電話番号18332752266
ウェブサイトhttps://aclarion.com/
企業コードACON
上場日Apr 22, 2022
最高経営責任者「CEO」Mr. Brent Ness
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし